Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
SAT-163 Inflammation-associated gene expression profiles distinguishing significant fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD): evidence from a Turkish patient cohort
Date
2026-05-27
Author
Kahraman, Deniz Cansen
Sinoplu, Esra
Turan Gökçe, Dilara
Kiremitci, Saba
İdilman, Ramazan
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
54
views
0
downloads
Cite This
URI
https://www.sciencedirect.com/science/article/pii/S0168827826018167?via%3Dihub
https://hdl.handle.net/11511/119558
DOI
https://doi.org/10.1016/s0168-8278(26)01816-7
Conference Name
EASL Congress 2026
Collections
Graduate School of Informatics, Conference / Seminar
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
D. C. Kahraman, E. Sinoplu, D. Turan Gökçe, S. Kiremitci, and R. İdilman, “SAT-163 Inflammation-associated gene expression profiles distinguishing significant fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD): evidence from a Turkish patient cohort,” presented at the EASL Congress 2026, Barcelona, İspanya, 2026, Accessed: 00, 2026. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S0168827826018167?via%3Dihub.